J&J shares vaccine results

Top 10 Results

1.J&J shares vaccine results

J&J shares vaccine results Johnson & Johnson said its single-shot coronavirus vaccine was 66% effective at preventing moderate to severe disease in a large clinical trial, although the figure …

2.J&J shares vaccine results

The issue is that J&J does not have a large number of doses to deliver immediately, with its pledge of 100 million doses of vaccine for the U.S. aimed at June 2021. Manufacturing should ramp in …

3.J&J shares vaccine results

Shares of Johnson & Johnson JNJ, 0.84% were up 0.9% in trading on Monday, as the company nears the anticipated disclosure of interim results from a late-stage clinical trial evaluating its…

4.J&J shares vaccine results

Johnson & Johnson chief scientific officer Dr. Paul Stoffels joins “Squawk on the Street” to discuss the results of its Covid vaccine trials. … Share Share Article via … J&J says its one-shot …

5.J&J shares vaccine results

J&J’s results produced more evidence that the variants will be harder to ward off. In the U.S., where mutations aren’t thought to be as widespread, the vaccine was 72% effective. But in South…

6.J&J shares vaccine results

A single dose of Johnson & Johnson’s experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus, according to interim results from an early-to-mid stage clinical…

7.J&J shares vaccine results

Johnson & Johnson expects to report results from the eagerly-anticipated clinical trial of its COVID-19 vaccine next week, the US pharmaceutical’s chief financial officer told CNBC Tuesday.

8.J&J shares vaccine results

Dow Jones pharmaceutical giant J&J is the only one of six U.S. government-backed efforts testing a single-shot coronavirus vaccine. But Johnson & Johnson will have to overcome a huge bar. Pfizer ‘s…

9.J&J shares vaccine results

J&J’s vaccine can also be shipped and stored at refrigerator temperatures, rather than the ultra-cold temperatures required for Pfizer’s and Moderna’s. In the U.S., the federal government pre-ordered 100 million doses from J&J, which would expand the vaccine supply available to the country by 25% if study results are positive.

10.J&J shares vaccine results

Results from the preliminary Phase 1 and 2 study of the Johnson & Johnson vaccine were published last week. They showed that the vaccine was safe and that 90% of its recipients produced antibodies…

News results

1.J&J Vaccine Provides Strong Shield Against Severe Covid

Johnson & Johnson’s one-shot vaccine generated strong protection against Covid-19 in a large, late-stage trial, raising hopes that it can rapidly reshape a stumbling immunization campaign.

Published Date: 2021-01-29T22:10:00.0000000Z

2.Wall St. drops after J&J vaccine data, GameStop effect weighs

U.S. stock indexes dropped, closing out the Friday session with the biggest weekly fall since October, as investors gauged the ramifications of Johnson & Johnson’s COVID-19 vaccine trial results, while a standoff between Wall Street hedge funds and small,

Published Date: 2021-01-30T05:33:00.0000000Z

1  J&J Covid-19 Vaccine Is 66% Effective in Global Clinical Trial
Johnson & Johnson’s one-shot vaccine generated strong protection against Covid-19 in a large, late-stage trial, raising hopes that it can rapidly reshape a stumbling immunization campaign. In a study of more than 44,000 people, the vaccine prevented 66% of moderate to severe cases of Covid-19, according to a company statement Friday. And it …
Watch Video:

1.Moderna COVID-19 vaccine

Moderna COVID-19 Vaccine, codenamed mRNA-1273, is a COVID-19 vaccine developed by the United States National Institute of Allergy and Infectious Diseases…

2.Pfizer–BioNTech COVID-19 vaccine

The Pfizer–BioNTech COVID‑19 vaccine, sold under the brand name Comirnaty, is a COVID-19 vaccine developed by BioNTech in cooperation with Pfizer. It…


celecoxib), an anti-inflammatory drug; and Prevnar 13, a pneumococcal conjugate vaccine. In 2016, Pfizer Inc. was expected to merge with Allergan to create the…

Leave a Reply